Related Experiment Video
Updated: Sep 16, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Tripartite motif 47 promotes the development of thyroid carcinoma through ADAR ubiquitination
Hongzhou Liu1, Xiaodong Hu2, Tan Li2
1Department of Endocrinology, First Hospital of Handan City, Handan, 056002, Hebei Province, China.
Background:
Tripartite motif 47 (TRIM47) plays a vital role in the carcinogenesis and drug resistance of various cancers, whereas the function of TRIM47 in thyroid carcinoma (TC) remains unclear.
Methods:
Human study and animal experiments were performed. Mass spectrometry, cellular invasion/metastasis assay, chemo-resistance assay, and ubiquitination evaluation were conducted to investigate the interaction between TRIM47 and adenosine deaminases acting on RNA (ADAR).
Results:
TRIM47 expression was increased in human tissues and cell lines of TC. Functional experiments demonstrated that TRIM47 expression enhanced malignant biological behaviors. With mass spectrometry, TRIM47 silencing could significantly decrease the chemo-resistance of TC cells to chemotherapeutic drugs. The interaction between TRIM47 and ADAR was mediated through the ubiquitin-proteasome pathway (UPP), which was approved by RNA interference procedure and co-immunoprecipitation.
Conclusion:
Comprehensively, glycogen synthase kinase-3β (GSK-3β)-associated ubiquitination is critical in the TRIM47-ADAR-GSK-3β axis. This study demonstrates that TRIM47 interacted with ADAR to facilitate ADAR protein degradation via ubiquitination and GSK-3β-associated phosphorylation, which serves as a novel therapeutic avenue for TC.
Insights
Tripartite motif 47 (TRIM47) promotes thyroid cancer progression and chemoresistance by interacting with adenosine deaminases acting on RNA (ADAR). This interaction involves ubiquitination and GSK-3β phosphorylation, offering a new therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Tripartite motif 47 (TRIM47) is implicated in various cancers, but its role in thyroid carcinoma (TC) is unknown.
- Understanding TRIM47's function in TC is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of TRIM47 in thyroid carcinoma (TC).
- To elucidate the interaction between TRIM47 and adenosine deaminases acting on RNA (ADAR) in TC.
Main Methods:
- Human and animal studies utilizing mass spectrometry, invasion/metastasis assays, chemo-resistance assays, and ubiquitination evaluation.
- Investigated the TRIM47-ADAR interaction and its regulation via the ubiquitin-proteasome pathway (UPP).
Main Results:
- TRIM47 expression is elevated in TC tissues and cell lines, enhancing malignant behaviors.
- TRIM47 silencing reduced chemoresistance in TC cells.
- TRIM47 interacts with ADAR, leading to ADAR protein degradation through ubiquitination and GSK-3β-associated phosphorylation.
Conclusions:
- The TRIM47-ADAR-GSK-3β axis is critical in TC pathogenesis.
- TRIM47 facilitates ADAR degradation via ubiquitination and GSK-3β phosphorylation.
- This axis presents a novel therapeutic strategy for thyroid carcinoma.
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...

